These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 35845137)
1. A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy. Wang Y; Liu J; Zhang L; Li Y Dis Markers; 2022; 2022():6402599. PubMed ID: 35845137 [TBL] [Abstract][Full Text] [Related]
2. Pyroptosis-Related Gene Signature Predicts the Prognosis of ccRCC Using TCGA and Single-Cell RNA Seq Database. Gan Y; Zhang Z; Wang X; Li A; Fan Y; Zhang Q J Healthc Eng; 2022; 2022():8224618. PubMed ID: 36349258 [TBL] [Abstract][Full Text] [Related]
3. Pyroptosis-Related Subtypes Predict the Response of Clear Cell Renal Cell Carcinoma to Targeted Therapy. Ma J; Kang Z; Yang G; Wang X; Si M; Wang Y; Li G; Bai S; Zeng F; Li M; Wang Z; Wang L; Xu W Front Biosci (Landmark Ed); 2023 Dec; 28(12):334. PubMed ID: 38179741 [TBL] [Abstract][Full Text] [Related]
4. Identification of immune subtypes to guide immunotherapy and targeted therapy in clear cell renal cell carcinoma. Xu C; Li Y; Su W; Wang Z; Ma Z; Zhou L; Zhou Y; Chen J; Jiang M; Liu M Aging (Albany NY); 2022 Sep; 14(17):6917-6935. PubMed ID: 36057262 [TBL] [Abstract][Full Text] [Related]
5. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma. Zhou S; Lu Y; Chen Y; Gan W Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108 [TBL] [Abstract][Full Text] [Related]
6. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related]
7. Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma. Hua S; Xie Z; Zhang Y; Wu L; Shi F; Wang X; Xia S; Dong S; Jiang J Front Immunol; 2022; 13():869297. PubMed ID: 35936012 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Evaluation of the m Yu M; Liu X; Xu H; Shen S; Wang F; Chen D; Li G; Wang Z; Zuo Z; Zhao A Front Immunol; 2022; 13():818120. PubMed ID: 35784363 [TBL] [Abstract][Full Text] [Related]
9. A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma. Li Z; Xia Z; Yu Y; Cai L; Jian W; Wang T; Xue W; Wang X; Wang B; Zhang P; Yao W; Zhang C; Wang C BMC Med Genomics; 2022 Sep; 15(1):204. PubMed ID: 36163033 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma. Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z Front Immunol; 2022; 13():934243. PubMed ID: 36189255 [TBL] [Abstract][Full Text] [Related]
11. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma. Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304 [TBL] [Abstract][Full Text] [Related]
12. Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients. Chen J; Jiang R; Guan W; Cao Q; Tian Y; Dong K; Pan X; Cui X Int J Med Sci; 2024; 21(3):496-507. PubMed ID: 38250606 [No Abstract] [Full Text] [Related]
13. A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma. Pan XQ; Huang W; Jin LW; Lin HZ; Xu XY Dis Markers; 2022; 2022():8093837. PubMed ID: 35308143 [TBL] [Abstract][Full Text] [Related]
14. Novel immune-related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Jun; 36(6):e24409. PubMed ID: 35441741 [TBL] [Abstract][Full Text] [Related]
15. Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy. Zhou X; Yao L; Zhou X; Cong R; Luan J; Wei X; Zhang X; Song N Front Oncol; 2022; 12():837155. PubMed ID: 35860590 [TBL] [Abstract][Full Text] [Related]
16. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma. Zhang D; Zhao F; Li J; Qin X; Li S; Niu R Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524 [TBL] [Abstract][Full Text] [Related]
17. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma. Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J Front Immunol; 2022; 13():1021935. PubMed ID: 36248876 [TBL] [Abstract][Full Text] [Related]
18. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma. Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816 [TBL] [Abstract][Full Text] [Related]
19. LASSO regression and WGCNA-based telomerase-associated lncRNA signaling predicts clear cell renal cell carcinoma prognosis and immunotherapy response. Shen C; Jiang K; Zhang W; Su B; Wang Z; Chen X; Zheng B; He T Aging (Albany NY); 2024 May; 16(11):9386-9409. PubMed ID: 38819232 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of a tryptophan metabolism-related model in the prognostic prediction and immune status for clear cell renal carcinoma. Yao Q; Zhang X; Wang Y; Wang C; Wei C; Chen J; Chen D Eur J Med Res; 2024 Jan; 29(1):22. PubMed ID: 38183155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]